{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:09:12Z","timestamp":1789711752300,"version":"4.0.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer is one of the most common cancers in women, particularly among women living with HIV. High-risk human papillomavirus (Hr-HPV) is the main causative agent of this cancer, but the prevalence of Hr-HPV infection among women living with HIV in Kinshasa remains poorly documented. The objective of this study was to determine this prevalence and identify associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among women living with HIV aged 25\u201365 years receiving antiretroviral therapy at the DREAM Center in Kinshasa. Participants were consecutively recruited among eligible women attending the center during the study period. Cervical samples were collected using the Abbott Cervi\u2013Collect kit and analyzed for Hr-HPV genotyping using the Abbott RealTime HPV assay on the m2000 platform, a real-time PCR method detecting HPV-16, HPV-18, and a pooled group of 12 additional high-risk HPV types with an internal \u03b2-globin control for sample quality assurance. Sociodemographic and clinical data were collected using structured questionnaires.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 436 women were included in the analysis. The prevalence of Hr-HPV infection was 47.7%. Of these, 23.79 % were infected with oncogenic HPV-16 and\u221218 types (alone or in co-infection with other types). In a logistic regression analysis, WHO clinical stage 3 and 4, duration of antiretroviral therapy for less than 2 years, and HIV viral load greater than or equal to 1,000 copies\/ml showed statistically significant associations with Hr-HPV infection, with adjusted ORs of 1.75 (1.16\u20132.64;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008), 1.91 (1.07\u20133.41;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.028), and 3.13 (1.30\u20137.54;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.011), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals a high prevalence of Hr-HPV infection among women living with HIV in Kinshasa. Non-16\/18 HPV types were predominant, while HPV-16 and HPV-18 were detected in approximately one in four Hr-HPV-positive women. Advanced HIV disease (WHO clinical stages 3 and 4), unsuppressed HIV viral load, and shorter duration of antiretroviral therapy were independently associated with Hr-HPV infection. These findings underscore the potential value of broader HPV vaccine coverage, including higher-valent vaccines, alongside strengthened cervical cancer screening as part of comprehensive cervical cancer prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1914799","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:40Z","timestamp":1789709920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, high-risk HPV type profile, and factors associated with high-risk HPV infection among women living with HIV in Kinshasa, Democratic Republic of the Congo"],"prefix":"10.3389","volume":"14","author":[{"given":"Julien","family":"Neze-Sebakunzi","sequence":"first","affiliation":[{"name":"Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa","place":["Kinshasa, Democratic Republic of Congo"]},{"name":"Community of Sant'Egidio, DREAM Program DRC","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Doro Altan","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi Link","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Ceffa","sequence":"additional","affiliation":[{"name":"Community of Sant'Egidio, DREAM Program Europe","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guidotti","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Locale (ASL) Roma 1","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Capparucci","sequence":"additional","affiliation":[{"name":"Community of Sant'Egidio, DREAM Program Europe","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Ciccacci","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Musikingala","sequence":"additional","affiliation":[{"name":"Community of Sant'Egidio, DREAM Program DRC","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Nkuba-Ndaye","sequence":"additional","affiliation":[{"name":"Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Makangara-Cigolo","sequence":"additional","affiliation":[{"name":"Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul Kompany","family":"Kisenzele","sequence":"additional","affiliation":[{"name":"Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tr\u00e9sor","family":"Kabeya-Mampuela","sequence":"additional","affiliation":[{"name":"Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Orlando","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Ahuka-Mundeke","sequence":"additional","affiliation":[{"name":"Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","article-title":"Cervical cancer: Epidemiology, risk factors and screening","volume":"32","author":"Zhang","year":"2020","journal-title":"Chin J Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bpobgyn.2004.10.002","article-title":"HIV and cancer of the cervic","volume":"19","author":"Chirenje","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet."},{"key":"B4","author":"Bouvard","year":"2021","journal-title":"The IARC Perspective on Cervical Cancer Screening"},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1371\/journal.pone.0218762","article-title":"Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana","volume":"1","author":"Krings","year":"2019","journal-title":"PLoS ONE."},{"key":"B6","article-title":"Geneva: World Health Organization; 2021","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3322\/caac.21696","article-title":"Cervical cancer prevention and control in women living with human immunodeficiency virus","volume":"71","author":"Castle","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","article-title":"Cervical cancer screening: past, present, and future","volume":"8","author":"Bedell","year":"2020","journal-title":"Sex Med Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10552-009-9475-z","article-title":"Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa","volume":"21","author":"Firnhaber","year":"2010","journal-title":"Cancer Causes Control."},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gofs.2021.07.001","article-title":"Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa","volume":"50","author":"Kajimina Katumbayi","year":"2022","journal-title":"Gynecologie Obstetrique Fertilite et Senologie."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.00110","article-title":"Prevalence and distribution of human papillomavirus genotypes among women in Kinshasa, The Democratic Republic of the Congo","volume":"5","author":"Mutombo","year":"2019","journal-title":"J Global Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jgyn.2014.12.021","article-title":"\u00c9pid\u00e9miologie et caract\u00e9risation des g\u00e9notypes \u00e0 haut risque de Papillomavirus humain dans une population d'adolescentes sexuellement actives \u00e0 Ouagadougou","volume":"44","author":"Ou\u00e9draogo","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod."},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-024-00596-1","article-title":"High-risk human papillomavirus genotyping in cervical cancers in Tanzania","volume":"1","author":"Murenzi","year":"2024","journal-title":"Infect Agent Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pvr.2018.09.001","article-title":"Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa","volume":"6","author":"Ouedraogo","year":"2018","journal-title":"Papillomavirus Research."},{"key":"B16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fonc.2019.00355","article-title":"Mucosal and cutaneous human papillomavirus infections and cancer biology","volume":"9","author":"Gheit","year":"2019","journal-title":"Front Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1773-035X(08)74276-X","article-title":"and cancer: Mechanisms of oncogenesis","volume":"38","author":"Mougin","year":"2008","journal-title":"Revue Francophone des Laboratoires."},{"key":"B18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/cncr.34006","article-title":"Cervical cancer prevention: human papillomavirus testing as primary screening","volume":"128","author":"Desai","year":"2022","journal-title":"Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Lin, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV."},{"key":"B21","doi-asserted-by":"publisher","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1128\/JCM.44.5.1788-1791.2006","article-title":"Comparative evaluation of the performance of the abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation","volume":"44","author":"Garcia-Diaz","year":"2006","journal-title":"J Clin Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","article-title":"Principles and analytical performance of Abbott real time high risk HPV test","volume":"45","author":"Huang","year":"2009","journal-title":"J Clin Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3390\/microorganisms10122492","article-title":"Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)\u2014implications for pathogenicity and vaccine effectiveness","volume":"10","author":"Iglesias","year":"2022","journal-title":"Microorganisms."},{"key":"B25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/OLQ.0b013e3181fc6ec0","article-title":"Prevalence and determinants of high-risk human papillomavirus infection in women from a Sub-Saharan African community","volume":"1","author":"Sangwa-Lugoma","year":"2011","journal-title":"Sexually Transmitted Diseases."},{"key":"B26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/14787210.2017.1322902","article-title":"Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease","volume":"15","author":"Mboumba Bouassa","year":"2017","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.gyobfe.2008.02.007","article-title":"Fr\u00e9quence, persistance et r\u00e9cidive des l\u00e9sions \u00e0 HPV du col ut\u00e9rin chez les patientes s\u00e9ropositives pour le VIH","volume":"36","author":"Berr\u00e9bi","year":"2008","journal-title":"Gynecologie Obstetrique et Fertilite."},{"key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12905-024-03249-y","article-title":"Factors associated with human papillomavirus infections among women living with HIV in public health facilities in Western Oromia, Ethiopia","author":"Abdi","year":"2024","journal-title":"BMC Womens Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12905-015-0172-7","article-title":"Risk factors for high-risk and multi-type human papillomavirus infections among women in Ho Chi Minh city, Vietnam: a cross-sectional study","volume":"21","author":"Tran","year":"2015","journal-title":"BMC Womens Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1186\/s12889-024-19240-z","article-title":"Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross-sectional study","volume":"24","author":"Ashry","year":"2024","journal-title":"BMC Public Health."},{"key":"B31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.34172\/ehsj.25209","article-title":"The prevalence of human papillomavirus in women living with HIV in Mukono general hospital, Uganda","volume":"10","author":"Nantale","year":"2023","journal-title":"Epidemiol Health System j."},{"key":"B32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12885-024-11928-0","article-title":"Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda","volume":"24","author":"Nakigozi","year":"2024","journal-title":"BMC Cancer."},{"key":"B33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/CEJ.0000000000000802","article-title":"Screening approaches for cervical cancer in Mozambique in HIV positive and negative women","volume":"32","author":"Sineque","year":"2023","journal-title":"Eur J Cancer Prev."},{"key":"B34","first-page":"273","article-title":"Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV\/AIDS: effect of anti-retroviral therapy","author":"Kelly","year":""},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0257324","DOI":"10.1371\/journal.pone.0257324","article-title":"High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women","volume":"16","author":"Kuguyo","year":"2021","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1158\/1055-9965.EPI-20-0969","article-title":"HPV Types in cervical precancer by HIV status and birth region: a population-based register study","volume":"29","author":"Christina","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12905-024-03232-7","article-title":"Prediction of precancerous cervical cancer lesions among women living with HIV on antiretroviral therapy in Uganda: a comparison of supervised machine learning algorithms","volume":"24","author":"Namalinzi","year":"2024","journal-title":"BMC Womens Health."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0303535","DOI":"10.1371\/journal.pone.0303535","article-title":"Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana","volume":"19","author":"Gyane","year":"2024","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13027-023-00513-y","article-title":"High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting","volume":"18","author":"Akakpo","year":"2023","journal-title":"Infect Agent Cancer."},{"key":"B40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/QAD.0000000000003437","article-title":"High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa","volume":"37","author":"Chachage","year":"2023","journal-title":"AIDS."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"De Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1914799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:41Z","timestamp":1789709921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1914799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":41,"alternative-id":["10.3389\/fpubh.2026.1914799"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1914799","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1914799"}}